30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Akcea Therapeutics Inc (AKCA)

Track

Stock chart
Ticker: AKCA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
IONIS PHARMACEUTICALS INC
1 purchase — total 385,464,527 USD
Buy 10 Oct 2020
Value US$2,909,350.48 | Price 321.38 | Shares 86,460
Sale 22 Sep 2020
Value US$4,227,151.58 | Price 53.35 | Shares 58,442
Sale 22 Sep 2020
Value US$13,046.40 | Price 18.12 | Shares 720
Sale 22 Sep 2020
Value US$5,780.28 | Price 18.12 | Shares 319
Sale 17 Jul 2020
Value US$3,287.79 | Price 12.50 | Shares 263
Sale 23 Mar 2020
Value US$3,938.09 | Price 11.76 | Shares 335
Sale 23 Mar 2020
Value US$37,578.74 | Price 11.75 | Shares 3,198
Sale 23 Mar 2020
Value US$110,648.81 | Price 11.75 | Shares 9,417
Sale 23 Mar 2020
Value US$9,153.48 | Price 11.75 | Shares 779
Sale 15 Jul 2019
Value US$42,782.88 | Price 23.52 | Shares 1,819
Planned sale 8 Apr 2019
Value US$57,480.28 | Price 32.17 | Shares 1,787
Planned sale 8 Apr 2019
Value US$634,418.00 | Price 31.72 | Shares 20,000
Planned sale 5 Apr 2019
Value US$963,300.00 | Price 32.11 | Shares 30,000
Planned sale 5 Apr 2019
Value US$951,300.00 | Price 31.71 | Shares 30,000
Planned sale 6 Mar 2019
Value US$590,856.17 | Price 32.14 | Shares 18,386
Buy 17 Apr 2018
Value US$199,999,987.50 | Price 18.75 | Shares 10,666,666
Buy 19 Jul 2017
Value US$25,000,000.00 | Price 8.00 | Shares 3,125,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-10-14 2020-10-10 B Purchase
IONIS PHARMACEUTICALS INC
Large shareholder
86,460 +12.3%
321.38
US$2,909,350 		86,460 +12.3% 321.38 US$2,909,350
2020-09-24 2020-09-22 S Sale
McDevitt Damien

Chief Executive Officer

Executive Director
58,442 -41.6%
53.35
US$4,227,152 		58,442 -41.6% 53.35 US$4,227,152
2020-09-24 2020-09-22 S Sale
2.1
Jenne Kyle

Chief Commercial Officer

Officer
1,732 -40.4%
19.08
US$4,920,697 		1,732 -40.4% 19.08 US$4,920,697
2020-09-24 2020-09-22 S Sale
Patterson Joshua F.

General Counsel

Officer
319 -1.2%
18.12
US$5,780 		319 -1.2% 18.12 US$5,780
2020-07-20 2020-07-17 S Sale
Patterson Joshua F.

General Counsel

Officer
263 -1.0%
12.50
US$3,288 		263 -1.0% 12.50 US$3,288
2020-03-25 2020-03-23 S Sale
Patterson Joshua F.

General Counsel

Officer
335 -2.2%
11.76
US$3,938 		335 -2.2% 11.76 US$3,938
2020-03-25 2020-03-23 S Sale
O'Dea Louis

Chief Medical Officer

Officer
3,198 -4.9%
11.75
US$37,579 		3,198 -4.9% 11.75 US$37,579
2020-03-25 2020-03-23 S Sale
McDevitt Damien

Chief Executive Officer

Executive Director
9,417 -3.7%
11.75
US$110,649 		9,417 -3.7% 11.75 US$110,649
2020-03-25 2020-03-23 S Sale
2.1
Jenne Kyle

Chief Commercial Officer

Officer
779 -1.5%
11.75
US$9,153 		779 -1.5% 11.75 US$9,153
2019-07-17 2019-07-15 S Sale
3.5
Boyce Sarah

President

Executive Director
1,819 -8.4%
23.52
US$42,783 		1,819 -8.4% 23.52 US$42,783
2019-04-09 2019-04-08 PlS Planned sale
2.8
Soteropoulos Paula

Chief Executive Officer

Executive Director
1,787 -100.0%
32.17
US$57,480 		1,787 -100.0% 32.17 US$57,480
2019-04-09 2019-04-08 PlS Planned sale
Goldberg Jeff Marc

Chief Operating Officer
20,000 -87.4%
31.72
US$634,418 		20,000 -87.4% 31.72 US$634,418
2019-04-09 2019-04-05 PlS Planned sale
2.8
Soteropoulos Paula

Chief Executive Officer

Executive Director
30,000 -100.0%
32.11
US$963,300 		30,000 -100.0% 32.11 US$963,300
2019-04-09 2019-04-05 PlS Planned sale
Goldberg Jeff Marc

Chief Operating Officer
30,000 -91.2%
31.71
US$951,300 		30,000 -91.2% 31.71 US$951,300
2019-03-07 2019-03-06 PlS Planned sale
2.8
Soteropoulos Paula

Chief Executive Officer

Executive Director
18,386 -100.0%
32.14
US$590,856 		18,386 -100.0% 32.14 US$590,856
2018-04-19 2018-04-17 B Purchase IONIS PHARMACEUTICALS INC Large shareholder
10,666,666 +20.0%
18.75
US$199,999,988 		10,666,666 +20.0% 18.75 US$199,999,988
2017-07-21 2017-07-19 B Purchase IONIS PHARMACEUTICALS INC Large shareholder
3,125,000 +7.4%
8.00
US$25,000,000 		3,125,000 +7.4% 8.00 US$25,000,000
Explore more

More insider trading research around Akcea Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America